AOD-9604 is a modified fragment of human growth hormone (HGH), studied for its potential role in fat metabolism and weight regulation without directly affecting blood sugar or growth hormone levels.

Potential research benefits include:

• Supporting fat breakdown and metabolism

• Studied for effects on reduced abdominal and visceral fat

• Investigated for potential joint and cartilage repair support

​

Retatrutide is a novel investigational peptide studied for its triple-receptor activity, making it a next-generation candidate for metabolic research.

Potential research benefits include:

• Supporting appetite regulation and satiety

• Studied for enhanced fat metabolism and weight management

• Investigated for synergistic effects on glucose and energy balance

​

Semaglutide is a GLP-1 receptor agonist researched and approved for type 2 diabetes and obesity management. In research settings, it is studied for its effects on appetite and metabolic balance.

Potential research benefits include:

• Supporting appetite control and satiety

• Enhancing blood sugar regulation and insulin sensitivity

• Studied for weight loss and cardiometabolic support

​

This combination pairs Tirzepatide’s dual metabolic action with BPC-157’s regenerative properties. It is investigated as a comprehensive approach to both metabolic balance and recovery.

Potential research benefits include:

• Supporting fat metabolism and blood sugar regulation

• Promoting muscle, tendon, and gut tissue repair

• Studied for integrated effects on body composition and healing

​

MOTS-C is a mitochondrial-derived peptide being studied for its role in energy regulation and cellular stress response. Research suggests it may help optimize metabolism and resilience at the cellular level.

Potential research benefits include:

• Supporting mitochondrial function and energy balance

• Investigated for insulin sensitivity and metabolic flexibility

• Studied for potential roles in healthy aging and cellular protection

​

This research blend combines Semaglutide’s metabolic regulation with BPC-157’s tissue repair properties, creating a dual-focus formula under study for both body composition and recovery.

Potential research benefits include:

• Supporting weight management and appetite regulation

• Promoting tissue healing and gut health

• Studied for synergistic effects in metabolic recovery

​

Tirzepatide is a synthetic peptide analog studied for its dual activity on GLP-1 and GIP receptors, offering potential benefits for blood sugar control and weight management.

Potential research benefits include:

• Supporting improved glucose regulation

• Investigated for reduced body fat and improved body composition

• Studied for potential cardiometabolic health applications

​